Swedencare
+FollowCoverage
- Addtech
- Alcadon
- Arise
- Avensia
- Bergs Timber
- BioGaia
- Biovica
- Boule Diagnostics
- Bredband2
- Brighter
- Briox
- Capacent
- Catella
- Catena
- Catena Media
- Cavotec
- Christian Berner Tech Trade
- Concordia Maritime
- CTT Systems
- Dedicare
- DistIT
- Diös
- Doro
- Elanders
- Electra Gruppen
- Elos Medtech
- Empir Group
- Enzymatica
- Eolus Vind
- Eurocon
- eWork
- FastPartner
- Ferronordic
- Formpipe
- Fortnox
- Future Gaming Group
- G5 Entertainment
- GARO
- Generic
- Hifab
- Hoylu
- Intervacc
- INVISIO Communications
- ITAB Shop Concept
- JLT Mobile Computers
- Lagercrantz
- Lammhults
- Leading Edge Materials
- Magnolia Bostad
- MedicaNatumin
- Midsona
- Moment Group
- Motion Display
- NAXS
- Nilörngruppen
- Nolato
- Nordic Leisure
- Nordic Waterproofing
- Opus Group
- Poolia
- Pricer
- Proact
- Probi
- QuickCool
- Railcare
- Rottneros
- Seafire
- SinterCast
- SJR
- Stendörren
- Studsvik
- Swedencare
- Swedol
- TagMaster
- Tethys Oil
- THQ Nordic
- VBG Group
- Vitec
- Vitrolife
-
Zutec
Menu
- Addtech
- Alcadon
- Arise
- Avensia
- Bergs Timber
- BioGaia
- Biovica
- Boule Diagnostics
- Bredband2
- Brighter
- Briox
- Capacent
- Catella
- Catena
- Catena Media
- Cavotec
- Christian Berner Tech Trade
- Concordia Maritime
- CTT Systems
- Dedicare
- DistIT
- Diös
- Doro
- Elanders
- Electra Gruppen
- Elos Medtech
- Empir Group
- Enzymatica
- Eolus Vind
- Eurocon
- eWork
- FastPartner
- Ferronordic
- Formpipe
- Fortnox
- Future Gaming Group
- G5 Entertainment
- GARO
- Generic
- Hifab
- Hoylu
- Intervacc
- INVISIO Communications
- ITAB Shop Concept
- JLT Mobile Computers
- Lagercrantz
- Lammhults
- Leading Edge Materials
- Magnolia Bostad
- MedicaNatumin
- Midsona
- Moment Group
- Motion Display
- NAXS
- Nilörngruppen
- Nolato
- Nordic Leisure
- Nordic Waterproofing
- Opus Group
- Poolia
- Pricer
- Proact
- Probi
- QuickCool
- Railcare
- Rottneros
- Seafire
- SinterCast
- SJR
- Stendörren
- Studsvik
- Swedencare
- Swedol
- TagMaster
- Tethys Oil
- THQ Nordic
- VBG Group
- Vitec
- Vitrolife
-
Zutec
UPCOMING EVENTS
We arrange several open investor events with our covered companies each year. Please subscribe to get information about our upcoming Introduce events.
Premium animal health products
Swedencare
Swedencare is a high-growth animal health company that develops, promotes and sells OTC premium products within animal dental care. The company's main product, ProDen PlaqueOff, is proprietary, patented until 2021-2028 and sold in more than 50 countries. It reduces the amount of plaque, tartar as well as problems with bleeding gums and the target group is cats and dogs. Following acquisitions of its three largest distribution/sales partners in 2016, Swedencare has around 85% of its sales via direct sales and the remaining from external distributors.
Margin expansion from selling high margin ”PlaqueOff Powder ingredient” to food producers. Growth potential from continued launch of new products and/or products on new markets. We view China, Russia and Brazil as interesting growth markets. The net cash position and solid cash generation also leave room for more M&A and/or future dividends.
Strong dependency on the PlaqueOff formula, for which the patent runs out in 2021 in most markets. Increased competition from larger animal health care companies entering Swedencare’s niche in the animal dental care market. With a poor M&A track record, there are risks for acquisition integration issues and inflated acquisition multiples if Swedencare decides to embark on the M&A path. New product and market launches involve risk and Swedencare has a high release tempo.
Financials
Swedencare
| SEKm | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018e | 2018 | 2019e | 2019 | 2020e | 2020 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 101 | 18 | 18 | 24 | 24 | 27 | 27 | 54 | 54 | 85 | 85 | 101 | 101 | 133 | 133 | 168 | 168 | ||
| Sales growth (%) | 18,1 | N/A | N/A | 32,3 | 32,3 | 11 | 11 | 100,2 | 100,2 | 59,1 | 59,1 | 18,1 | 18,1 | 31,5 | 31,5 | 26,4 | 26,4 | ||
| EBITDA | 33 | 2 | 2 | 6 | 6 | 9 | 9 | 14 | 14 | 24 | 24 | 33 | 33 | 43 | 43 | 56 | 56 | ||
| EBITDA margin (%) | 32,4 | 11,5 | 11,5 | 25,7 | 25,7 | 32,8 | 32,8 | 26,1 | 26,1 | 27,5 | 27,5 | 32,4 | 32,4 | 32,1 | 32,1 | 33,1 | 33,1 | ||
| EBIT adj | 32 | -2 | -2 | 6 | 6 | 9 | 9 | 11 | 11 | 22 | 22 | 32 | 32 | 41 | 41 | 54 | 54 | ||
| EBIT adj margin (%) | 32,1 | -8,2 | -8,2 | 25,6 | 25,6 | 32,2 | 32,2 | 21,1 | 21,1 | 25,6 | 25,6 | 32,1 | 32,1 | 30,8 | 30,8 | 32,1 | 32,1 | ||
| Pretax profit | 32 | -1 | -1 | 6 | 6 | 9 | 9 | 12 | 12 | 21 | 21 | 32 | 32 | 40 | 40 | 54 | 54 | ||
| EPS rep | 1,62 | N/A | N/A | 0 | 0 | 0 | 0 | 0,62 | 0,62 | 1,08 | 1,08 | 1,62 | 1,62 | 2 | 2 | 2,65 | 2,65 | ||
| EPS growth (%) | 50,2 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 74 | 74 | 50,2 | 50,2 | 23,6 | 23,6 | 32,5 | 32,5 | ||
| EPS adj | 1,57 | N/A | N/A | 0 | 0 | 0 | 0 | 0,64 | 0,64 | 1,13 | 1,13 | 1,57 | 1,57 | 2 | 2 | 2,65 | 2,65 | ||
| DPS | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| EV/EBITDA (x) | 24,1 | N/A | N/A | 0 | 0 | 0 | 0 | 28,1 | 28,1 | 17,3 | 17,3 | 24,1 | 24,1 | 18,1 | 18,1 | 13,3 | 13,3 | ||
| EV/EBIT adj (x) | 24,3 | N/A | N/A | 0 | 0 | 0 | 0 | 34,9 | 34,9 | 18,6 | 18,6 | 24,3 | 24,3 | 18,8 | 18,8 | 13,7 | 13,7 | ||
| P/E (x) | 32 | N/A | N/A | 0 | 0 | 0 | 0 | 40 | 40 | 24,4 | 24,4 | 32 | 32 | 25,9 | 25,9 | 19,5 | 19,5 | ||
| P/E adj (x) | 33 | N/A | N/A | 0 | 0 | 0 | 0 | 38,8 | 38,8 | 23,3 | 23,3 | 33 | 33 | 25,9 | 25,9 | 19,5 | 19,5 | ||
| EV/sales (x) | 7,8 | N/A | N/A | 0 | 0 | 0 | 0 | 7,4 | 7,4 | 4,8 | 4,8 | 7,8 | 7,8 | 5,8 | 5,8 | 4,4 | 4,4 | ||
| FCF yield (%) | 2,5 | N/A | N/A | 0 | 0 | 0 | 0 | -8,8 | -8,8 | 2,8 | 2,8 | 2,5 | 2,5 | 3,3 | 3,3 | 4,6 | 4,6 | ||
| Dividend yield (%) | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Net IB debt/EBITDA | -0,9 | -0,2 | -0,2 | -0,5 | -0,5 | -0,5 | -0,5 | 0,3 | 0,3 | -0,3 | -0,3 | -0,9 | -0,9 | -1,1 | -1,1 | -1,4 | -1,4 |
| SEKm | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018e | 2018 | 2019e | 2019 | 2020e | 2020 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 101 | 18 | 18 | 24 | 24 | 27 | 27 | 54 | 54 | 85 | 85 | 101 | 101 | 133 | 133 | 168 | 168 | ||
| COGS | -26 | -8 | -8 | -9 | -9 | -9 | -9 | -12 | -12 | -22 | -22 | -26 | -26 | -36 | -36 | -46 | -46 | ||
| Gross profit | 75 | 11 | 11 | 15 | 15 | 18 | 18 | 42 | 42 | 64 | 64 | 75 | 75 | 97 | 97 | 122 | 122 | ||
| Other operating items | -42 | -9 | -9 | -9 | -9 | -9 | -9 | -28 | -28 | -40 | -40 | -42 | -42 | -54 | -54 | -66 | -66 | ||
| EBITDA | 33 | 2 | 2 | 6 | 6 | 9 | 9 | 14 | 14 | 24 | 24 | 33 | 33 | 43 | 43 | 56 | 56 | ||
| Depreciation on tangibles | -1 | N/A | N/A | 0 | 0 | 0 | 0 | -2 | -2 | -1 | -1 | -1 | -1 | -2 | -2 | -2 | -2 | ||
| Depreciation on intangibles | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| EBITA | 32 | 2 | 2 | 6 | 6 | 9 | 9 | 12 | 12 | 23 | 23 | 32 | 32 | 41 | 41 | 54 | 54 | ||
| Goodwill impairment charges | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Other impairment and amortisation | 1 | -4 | -4 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | 1 | 1 | 0 | 0 | 0 | 0 | ||
| EBIT | 32 | -2 | -2 | 6 | 6 | 9 | 9 | 11 | 11 | 22 | 22 | 32 | 32 | 41 | 41 | 54 | 54 | ||
| Other financial items | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Net financial items | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Associated income | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Other EO items | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Pretax profit | 32 | -1 | -1 | 6 | 6 | 9 | 9 | 12 | 12 | 21 | 21 | 32 | 32 | 40 | 40 | 54 | 54 | ||
| Tax | -7 | 1 | 1 | -3 | -3 | -2 | -2 | -2 | -2 | -4 | -4 | -7 | -7 | -9 | -9 | -12 | -12 | ||
| Net profit | 26 | N/A | N/A | 4 | 4 | 7 | 7 | 10 | 10 | 17 | 17 | 26 | 26 | 32 | 32 | 42 | 42 | ||
| Minority interest | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Net profit discontinued | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Net profit to shareholders | 26 | N/A | N/A | 4 | 4 | 7 | 7 | 10 | 10 | 17 | 17 | 26 | 26 | 32 | 32 | 42 | 42 | ||
| EPS | 1,62 | N/A | N/A | 0 | 0 | 0 | 0 | 0,62 | 0,62 | 1,08 | 1,08 | 1,62 | 1,62 | 2 | 2 | 2,65 | 2,65 | ||
| EPS Adj | 1,57 | N/A | N/A | 0 | 0 | 0 | 0 | 0,64 | 0,64 | 1,13 | 1,13 | 1,57 | 1,57 | 2 | 2 | 2,65 | 2,65 | ||
| Total extraordinary items after tax | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Tax rate (%) | -20,3 | -107,7 | -107,7 | -43,7 | -43,7 | -22,6 | -22,6 | -17,6 | -17,6 | -20,5 | -20,5 | -20,3 | -20,3 | -22 | -22 | -22 | -22 | ||
| Gross margin (%) | 74 | 58,5 | 58,5 | 61,8 | 61,8 | 67,3 | 67,3 | 78,3 | 78,3 | 74,4 | 74,4 | 74 | 74 | 72,8 | 72,8 | 72,5 | 72,5 | ||
| EBITDA margin (%) | 32,4 | 11,5 | 11,5 | 25,7 | 25,7 | 32,8 | 32,8 | 26,1 | 26,1 | 27,5 | 27,5 | 32,4 | 32,4 | 32,1 | 32,1 | 33,1 | 33,1 | ||
| EBITA margin (%) | 31,3 | 11,5 | 11,5 | 25,6 | 25,6 | 32,4 | 32,4 | 21,7 | 21,7 | 26,5 | 26,5 | 31,3 | 31,3 | 30,8 | 30,8 | 32,1 | 32,1 | ||
| EBIT margin (%) | 32,1 | -8,2 | -8,2 | 25,6 | 25,6 | 32,2 | 32,2 | 21,1 | 21,1 | 25,6 | 25,6 | 32,1 | 32,1 | 30,8 | 30,8 | 32,1 | 32,1 | ||
| Pretax margin (%) | 31,7 | -7,2 | -7,2 | 25,8 | 25,8 | 32,2 | 32,2 | 22,1 | 22,1 | 25 | 25 | 31,7 | 31,7 | 30,5 | 30,5 | 32 | 32 | ||
| Net margin (%) | 25,3 | 0,6 | 0,6 | 14,6 | 14,6 | 24,9 | 24,9 | 18,2 | 18,2 | 19,9 | 19,9 | 25,3 | 25,3 | 23,8 | 23,8 | 24,9 | 24,9 | ||
| Growth rates Y/Y | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| Sales growth (%) | 18,1 | N/A | N/A | 32,3 | 32,3 | 11 | 11 | 100,2 | 100,2 | 59,1 | 59,1 | 18,1 | 18,1 | 31,5 | 31,5 | 26,4 | 26,4 | ||
| EBITDA growth (%) | 38,9 | N/A | N/A | 194,8 | 194,8 | 41,8 | 41,8 | 59,7 | 59,7 | 67,5 | 67,5 | 38,9 | 38,9 | 30,4 | 30,4 | 30,4 | 30,4 | ||
| EBIT growth (%) | 48,2 | N/A | N/A | 512,9 | 512,9 | 39,4 | 39,4 | 31,1 | 31,1 | 93,3 | 93,3 | 48,2 | 48,2 | 25,9 | 25,9 | 32 | 32 | ||
| Net profit growth (%) | 50,2 | N/A | N/A | 0 | 0 | 90 | 90 | 46,3 | 46,3 | 74 | 74 | 50,2 | 50,2 | 23,6 | 23,6 | 32,5 | 32,5 | ||
| EPS growth (%) | 50,2 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 74 | 74 | 50,2 | 50,2 | 23,6 | 23,6 | 32,5 | 32,5 | ||
| Profitability | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| ROE (%) | 29,2 | N/A | N/A | 45,8 | 45,8 | 62,2 | 62,2 | 28 | 28 | 26 | 26 | 29,2 | 29,2 | 28,1 | 28,1 | 29,6 | 29,6 | ||
| ROE Adj (%) | 28,3 | N/A | N/A | 45,8 | 45,8 | 62,8 | 62,8 | 28,9 | 28,9 | 27,1 | 27,1 | 28,3 | 28,3 | 28,1 | 28,1 | 29,6 | 29,6 | ||
| ROCE (%) | 46,8 | N/A | N/A | 102,3 | 102,3 | 118,6 | 118,6 | 32,6 | 32,6 | 34,5 | 34,5 | 46,8 | 46,8 | 54,9 | 54,9 | 68,4 | 68,4 | ||
| ROCE Adj(%) | 45,7 | N/A | N/A | 102,3 | 102,3 | 119,5 | 119,5 | 33,5 | 33,5 | 35,7 | 35,7 | 45,7 | 45,7 | 54,9 | 54,9 | 68,4 | 68,4 | ||
| ROIC (%) | 37,3 | N/A | N/A | 57,6 | 57,6 | 91,8 | 91,8 | 26,8 | 26,8 | 27,4 | 27,4 | 37,3 | 37,3 | 42,8 | 42,8 | 53,4 | 53,4 | ||
| ROIC Adj (%) | 37,3 | N/A | N/A | 57,6 | 57,6 | 91,8 | 91,8 | 26,8 | 26,8 | 27,4 | 27,4 | 37,3 | 37,3 | 42,8 | 42,8 | 53,4 | 53,4 | ||
| Adj earnings numbers | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| EBITDA Adj | 33 | 2 | 2 | 6 | 6 | 9 | 9 | 14 | 14 | 24 | 24 | 33 | 33 | 43 | 43 | 56 | 56 | ||
| EBITDA Adj margin (%) | 32,4 | 11,5 | 11,5 | 25,7 | 25,7 | 32,8 | 32,8 | 26,1 | 26,1 | 27,5 | 27,5 | 32,4 | 32,4 | 32,1 | 32,1 | 33,1 | 33,1 | ||
| EBITA Adj | 32 | 2 | 2 | 6 | 6 | 9 | 9 | 12 | 12 | 23 | 23 | 32 | 32 | 41 | 41 | 54 | 54 | ||
| EBITA Adj margin (%) | 31,3 | 11,5 | 11,5 | 25,6 | 25,6 | 32,4 | 32,4 | 21,7 | 21,7 | 26,5 | 26,5 | 31,3 | 31,3 | 30,8 | 30,8 | 32,1 | 32,1 | ||
| EBIT Adj | 32 | -2 | -2 | 6 | 6 | 9 | 9 | 11 | 11 | 22 | 22 | 32 | 32 | 41 | 41 | 54 | 54 | ||
| EBIT Adj margin (%) | 32,1 | -8,2 | -8,2 | 25,6 | 25,6 | 32,2 | 32,2 | 21,1 | 21,1 | 25,6 | 25,6 | 32,1 | 32,1 | 30,8 | 30,8 | 32,1 | 32,1 | ||
| Pretax profit Adj | 31 | 2 | 2 | 6 | 6 | 9 | 9 | 12 | 12 | 22 | 22 | 31 | 31 | 40 | 40 | 54 | 54 | ||
| Net profit Adj | 25 | 4 | 4 | 4 | 4 | 7 | 7 | 10 | 10 | 18 | 18 | 25 | 25 | 32 | 32 | 42 | 42 | ||
| Net profit to shareholders Adj | 25 | 4 | 4 | 4 | 4 | 7 | 7 | 10 | 10 | 18 | 18 | 25 | 25 | 32 | 32 | 42 | 42 | ||
| Net Adj margin (%) | 24,5 | 20,3 | 20,3 | 14,6 | 14,6 | 25,1 | 25,1 | 18,8 | 18,8 | 20,8 | 20,8 | 24,5 | 24,5 | 23,8 | 23,8 | 24,9 | 24,9 |
| SEKm | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018e | 2018 | 2019e | 2019 | 2020e | 2020 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EBITDA | 33 | 2 | 2 | 6 | 6 | 9 | 9 | 14 | 14 | 24 | 24 | 33 | 33 | 43 | 43 | 56 | 56 | ||
| Net financial items | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Paid tax | -7 | 1 | 1 | -3 | -3 | -2 | -2 | -2 | -2 | -4 | -4 | -7 | -7 | -9 | -9 | -12 | -12 | ||
| Non-cash items | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Cash flow before change in WC | 26 | 6 | 6 | 3 | 3 | 6 | 6 | 12 | 12 | 19 | 19 | 26 | 26 | 33 | 33 | 43 | 43 | ||
| Change in WC | 1 | N/A | N/A | 1 | 1 | -3 | -3 | -1 | -1 | -4 | -4 | 1 | 1 | -6 | -6 | -5 | -5 | ||
| Operating cash flow | 28 | -1 | -1 | 4 | 4 | 4 | 4 | 2 | 2 | 13 | 13 | 28 | 28 | 28 | 28 | 39 | 39 | ||
| CAPEX tangible fixed assets | -8 | N/A | N/A | 0 | 0 | -2 | -2 | -36 | -36 | -1 | -1 | -8 | -8 | -1 | -1 | -1 | -1 | ||
| CAPEX intangible fixed assets | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Acquisitions and disposals | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Free cash flow | 21 | -1 | -1 | 4 | 4 | 2 | 2 | -34 | -34 | 12 | 12 | 21 | 21 | 27 | 27 | 38 | 38 | ||
| Dividend paid | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Share issues and buybacks | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Other non cash items | 0 | N/A | N/A | -2 | -2 | -1 | -1 | 26 | 26 | 0 | 0 | 0 | 0 | -8 | -8 | -8 | -8 | ||
| Decrease in net IB debt | 21 | N/A | N/A | 2 | 2 | 1 | 1 | -8 | -8 | 11 | 11 | 21 | 21 | 19 | 19 | 30 | 30 | ||
| Balance Sheet (SEKm) | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| Goodwill | 50 | N/A | N/A | 0 | 0 | 0 | 0 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | ||
| Indefinite intangible assets | 0 | N/A | N/A | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Definite intangible assets | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Tangible fixed assets | 10 | N/A | N/A | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 3 | 10 | 10 | 9 | 9 | 9 | 9 | ||
| Other fixed assets | 1 | N/A | N/A | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Fixed assets | 61 | N/A | N/A | 0 | 0 | 2 | 2 | 52 | 52 | 54 | 54 | 61 | 61 | 60 | 60 | 60 | 60 | ||
| Inventories | 12 | 2 | 2 | 2 | 2 | 2 | 2 | 7 | 7 | 8 | 8 | 12 | 12 | 17 | 17 | 21 | 21 | ||
| Receivables | 15 | 7 | 7 | 7 | 7 | 12 | 12 | 10 | 10 | 13 | 13 | 15 | 15 | 19 | 19 | 23 | 23 | ||
| Other current assets | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Cash and liquid assets | 39 | N/A | N/A | 3 | 3 | 3 | 3 | 21 | 21 | 24 | 24 | 39 | 39 | 58 | 58 | 88 | 88 | ||
| Total assets | 127 | 10 | 10 | 12 | 12 | 19 | 19 | 90 | 90 | 100 | 100 | 127 | 127 | 153 | 153 | 192 | 192 | ||
| Shareholders equity | 101 | 7 | 7 | 8 | 8 | 13 | 13 | 57 | 57 | 74 | 74 | 101 | 101 | 124 | 124 | 158 | 158 | ||
| Minority | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Total equity | 101 | 7 | 7 | 8 | 8 | 13 | 13 | 57 | 57 | 74 | 74 | 101 | 101 | 124 | 124 | 158 | 158 | ||
| Long-term debt | 11 | N/A | N/A | 0 | 0 | 0 | 0 | 25 | 25 | 17 | 17 | 11 | 11 | 11 | 11 | 11 | 11 | ||
| Pension debt | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Convertible debt | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Deferred tax | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Other long-term liabilities | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Short-term debt | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Accounts payable | 15 | 3 | 3 | 3 | 3 | 5 | 5 | 8 | 8 | 9 | 9 | 15 | 15 | 18 | 18 | 23 | 23 | ||
| Other current liabilities | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Total liabilities and equity | 90 | N/A | N/A | 0 | 0 | 10 | 10 | 12 | 12 | 19 | 19 | 90 | 90 | 100 | 100 | 127 | 127 | ||
| Net IB debt | -29 | N/A | N/A | -3 | -3 | -4 | -4 | 4 | 4 | -8 | -8 | -29 | -29 | -47 | -47 | -77 | -77 | ||
| Net IB debt excl. pension debt | -29 | N/A | N/A | -3 | -3 | -4 | -4 | 4 | 4 | -8 | -8 | -29 | -29 | -47 | -47 | -77 | -77 | ||
| Capital invested | 72 | 7 | 7 | 6 | 6 | 9 | 9 | 60 | 60 | 66 | 66 | 72 | 72 | 77 | 77 | 81 | 81 | ||
| Working capital | 12 | 7 | 7 | 5 | 5 | 8 | 8 | 9 | 9 | 13 | 13 | 12 | 12 | 17 | 17 | 22 | 22 | ||
| EV breakdown | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| Market cap. diluted (m) | 817 | N/A | N/A | 0 | 0 | 0 | 0 | 391 | 391 | 415 | 415 | 817 | 817 | 817 | 817 | 817 | 817 | ||
| Net IB debt Adj | -29 | N/A | N/A | -3 | -3 | -4 | -4 | 4 | 4 | -8 | -8 | -29 | -29 | -47 | -47 | -77 | -77 | ||
| Market value of minority | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Reversal of shares and participations | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Reversal of conv. debt assumed equity | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| EV | 788 | N/A | N/A | 0 | 0 | 0 | 0 | 395 | 395 | 407 | 407 | 788 | 788 | 769 | 769 | 740 | 740 | ||
| Capital efficiency (%) | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| Total assets turnover (%) | 89 | N/A | N/A | 227,6 | 227,6 | 177,8 | 177,8 | 99 | 99 | 90,1 | 90,1 | 89 | 89 | 94,7 | 94,7 | 97,3 | 97,3 | ||
| Capital invested turnover (%) | 145,7 | N/A | N/A | 399 | 399 | 368,2 | 368,2 | 154,6 | 154,6 | 134,7 | 134,7 | 145,7 | 145,7 | 178,4 | 178,4 | 212,9 | 212,9 | ||
| Capital employed turnover (%) | 145,7 | N/A | N/A | 398,9 | 398,9 | 368,2 | 368,2 | 154,5 | 154,5 | 134,7 | 134,7 | 145,7 | 145,7 | 178,4 | 178,4 | 212,9 | 212,9 | ||
| Inventories / sales (%) | 10,2 | N/A | N/A | 7,1 | 7,1 | 6,2 | 6,2 | 8,5 | 8,5 | 9,1 | 9,1 | 10,2 | 10,2 | 10,9 | 10,9 | 11,2 | 11,2 | ||
| Customer advances / sales (%) | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Payables / sales (%) | 11,9 | N/A | N/A | 12,2 | 12,2 | 16,2 | 16,2 | 12,7 | 12,7 | 9,9 | 9,9 | 11,9 | 11,9 | 12,5 | 12,5 | 12,1 | 12,1 | ||
| Working capital / sales (%) | 12,3 | N/A | N/A | 25 | 25 | 25,3 | 25,3 | 15,6 | 15,6 | 12,7 | 12,7 | 12,3 | 12,3 | 10,9 | 10,9 | 11,6 | 11,6 | ||
| Financial risk and debt service | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| Net debt / equity (%) | -28,5 | -6 | -6 | -33,8 | -33,8 | -31,2 | -31,2 | 6,7 | 6,7 | -10,4 | -10,4 | -28,5 | -28,5 | -38,2 | -38,2 | -48,9 | -48,9 | ||
| Net debt / market cap (%) | -3,5 | N/A | N/A | 0 | 0 | 0 | 0 | 1 | 1 | -2 | -2 | -3,5 | -3,5 | -5,8 | -5,8 | -9,5 | -9,5 | ||
| Equity ratio (%) | 79,2 | 72,6 | 72,6 | 72,1 | 72,1 | 70,7 | 70,7 | 63 | 63 | 74,3 | 74,3 | 79,2 | 79,2 | 81,1 | 81,1 | 82,5 | 82,5 | ||
| Net IB debt adj. / equity (%) | -28,5 | -6 | -6 | -33,8 | -33,8 | -31,2 | -31,2 | 6,7 | 6,7 | -10,4 | -10,4 | -28,5 | -28,5 | -38,2 | -38,2 | -48,9 | -48,9 | ||
| Current ratio (%) | 429,5 | 363,9 | 363,9 | 358,3 | 358,3 | 308,7 | 308,7 | 455 | 455 | 529,8 | 529,8 | 429,5 | 429,5 | 518,6 | 518,6 | 583,4 | 583,4 | ||
| EBITDA / net interest (%) | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Net IB debt / EBITDA (%) | -87,7 | -20,2 | -20,2 | -45,4 | -45,4 | -46,7 | -46,7 | 26,8 | 26,8 | -32,8 | -32,8 | -87,7 | -87,7 | -111,4 | -111,4 | -139,3 | -139,3 | ||
| Interest cover (%) | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SEKm | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018e | 2018 | 2019e | 2019 | 2020e | 2020 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares outstanding adj. | 16 | N/A | N/A | 0 | 0 | 0 | 0 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | ||
| Fully diluted shares Adj | 16 | N/A | N/A | 0 | 0 | 0 | 0 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | ||
| EPS | 1,62 | N/A | N/A | 0 | 0 | 0 | 0 | 0,62 | 0,62 | 1,08 | 1,08 | 1,62 | 1,62 | 2 | 2 | 2,65 | 2,65 | ||
| Dividend per share Adj | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| EPS Adj | 1,57 | N/A | N/A | 0 | 0 | 0 | 0 | 0,64 | 0,64 | 1,13 | 1,13 | 1,57 | 1,57 | 2 | 2 | 2,65 | 2,65 | ||
| BVPS | 6,39 | N/A | N/A | 0 | 0 | 0 | 0 | 3,59 | 3,59 | 4,71 | 4,71 | 6,39 | 6,39 | 7,88 | 7,88 | 10,03 | 10,03 | ||
| BVPS Adj | 3,23 | N/A | N/A | 0 | 0 | 0 | 0 | 0,43 | 0,43 | 1,54 | 1,54 | 3,23 | 3,23 | 4,72 | 4,72 | 6,87 | 6,87 | ||
| Net IB debt / share | -1,8 | N/A | N/A | 0 | 0 | 0 | 0 | 0,2 | 0,2 | -0,5 | -0,5 | -1,8 | -1,8 | -3 | -3 | -4,9 | -4,9 | ||
| Share price | 51,8 | N/A | N/A | 0 | 0 | 0 | 0 | 24,31 | 24,31 | 25,01 | 25,01 | 51,8 | 51,8 | 51,8 | 51,8 | 51,8 | 51,8 | ||
| Market cap. (m) | 817 | N/A | N/A | 0 | 0 | 0 | 0 | 383 | 383 | 394 | 394 | 817 | 817 | 817 | 817 | 817 | 817 | ||
| Valuation | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| P/E | 32 | N/A | N/A | 0 | 0 | 0 | 0 | 40 | 40 | 24,4 | 24,4 | 32 | 32 | 25,9 | 25,9 | 19,5 | 19,5 | ||
| EV/sales | 7,81 | N/A | N/A | 0 | 0 | 0 | 0 | 7,35 | 7,35 | 4,76 | 4,76 | 7,81 | 7,81 | 5,79 | 5,79 | 4,41 | 4,41 | ||
| EV/EBITDA | 24,1 | N/A | N/A | 0 | 0 | 0 | 0 | 28,1 | 28,1 | 17,3 | 17,3 | 24,1 | 24,1 | 18,1 | 18,1 | 13,3 | 13,3 | ||
| EV/EBITA | 24,9 | N/A | N/A | 0 | 0 | 0 | 0 | 33,9 | 33,9 | 18 | 18 | 24,9 | 24,9 | 18,8 | 18,8 | 13,7 | 13,7 | ||
| EV/EBIT | 24,3 | N/A | N/A | 0 | 0 | 0 | 0 | 34,9 | 34,9 | 18,6 | 18,6 | 24,3 | 24,3 | 18,8 | 18,8 | 13,7 | 13,7 | ||
| Dividend yield (%) | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| FCF yield (%) | 2,5 | N/A | N/A | 0 | 0 | 0 | 0 | -8,8 | -8,8 | 2,8 | 2,8 | 2,5 | 2,5 | 3,3 | 3,3 | 4,6 | 4,6 | ||
| P/BVPS | 8,11 | N/A | N/A | 0 | 0 | 0 | 0 | 6,9 | 6,9 | 5,59 | 5,59 | 8,11 | 8,11 | 6,57 | 6,57 | 5,17 | 5,17 | ||
| P/BVPS Adj | 16,06 | N/A | N/A | 0 | 0 | 0 | 0 | 57,21 | 57,21 | 17,03 | 17,03 | 16,06 | 16,06 | 10,97 | 10,97 | 7,54 | 7,54 | ||
| P/E Adj | 33 | N/A | N/A | 0 | 0 | 0 | 0 | 38,8 | 38,8 | 23,3 | 23,3 | 33 | 33 | 25,9 | 25,9 | 19,5 | 19,5 | ||
| EV/EBITDA Adj | 24,1 | N/A | N/A | 0 | 0 | 0 | 0 | 28,1 | 28,1 | 17,3 | 17,3 | 24,1 | 24,1 | 18,1 | 18,1 | 13,3 | 13,3 | ||
| EV/EBITA Adj | 24,9 | N/A | N/A | 0 | 0 | 0 | 0 | 33,9 | 33,9 | 18 | 18 | 24,9 | 24,9 | 18,8 | 18,8 | 13,7 | 13,7 | ||
| EV/EBIT Adj | 24,3 | N/A | N/A | 0 | 0 | 0 | 0 | 34,9 | 34,9 | 18,6 | 18,6 | 24,3 | 24,3 | 18,8 | 18,8 | 13,7 | 13,7 | ||
| EV/cap. employed | 10,9 | N/A | N/A | 0 | 0 | 0 | 0 | 6,5 | 6,5 | 6,1 | 6,1 | 10,9 | 10,9 | 10 | 10 | 9,2 | 9,2 | ||
| Investment ratios | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| Capex / sales | 7,7 | N/A | N/A | 0 | 0 | 6,7 | 6,7 | 67,4 | 67,4 | 1,1 | 1,1 | 7,7 | 7,7 | 0,8 | 0,8 | 0,6 | 0,6 | ||
| Capex / depreciation | 746,9 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 111,4 | 111,4 | 746,9 | 746,9 | 57,3 | 57,3 | 61,7 | 61,7 | ||
| Capex tangibles / tangible fixed assets | 77,1 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 32,2 | 32,2 | 77,1 | 77,1 | 10,7 | 10,7 | 11,4 | 11,4 | ||
| Capex intangibles / definite intangibles | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Depreciation on intangibles / definite intangibles | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Depreciation on tangibles / tangibles | 10,3 | 27,3 | 27,3 | 37,5 | 37,5 | 183,5 | 183,5 | 207 | 207 | 28,9 | 28,9 | 10,3 | 10,3 | 18,6 | 18,6 | 18,5 | 18,5 |
Equity research
Swedencare
Swedencare - Ready, set, pet
18 October 2018 Swedencare Preview of results
Media
Swedencare
Swedencare - Company presentation with CEO Håkan Lagerberg (in Swedish)
4 September 2018 Swedencare Media
Swedencare - Interview with CEO Håkan Lagerberg (in Swedish)
4 September 2018 Swedencare Media
Company news
Swedencare
Main shareholders
Swedencare
| Main shareholders | Share capital % | Voting shares % |
|---|---|---|
| Håkan Svanberg | 32.2 % | 32.2 % |
| Mastan AB (Håkan Lagerberg) | 13.3 % | 13.3 % |
| JCC Group Invest Sweden AB (Johan Bergdahl) | 13.3 % | 13.3 % |
| Staffan Persson | 5.1 % | 5.1 % |
| AMF Försäkring & Fonder | 4.8 % | 4.8 % |
| Handelsbanken Fonder | 2.9 % | 2.9 % |
| Aktia | 2.6 % | 2.6 % |
| Investment AB Öresund | 2.2 % | 2.2 % |
| Nordnet Pensionsförsäkring | 2.1 % | 2.1 % |
| Martin Shimko | 1.9 % | 1.9 % |
QUICK FACTS
- Håkan Lagerberg
- Per Malmström
- Retail
- www.swedencare.se
- First North
- 837,4 MSEK
- SECARE
- 14 Feb 2019
QUICK FACTS
- CEO
- Håkan Lagerberg
- Chairman
- Per Malmström
- List
- First North
- Industry
- Retail
QUICK FACTS
- Market Cap
- 837,4 MSEK
- Ticker
- SECARE
- Next report date
- 14 Feb 2019
- Website
- www.swedencare.se
Latest articles
-
Inbjudan till Introduce Investor Day 4 december
13 Nov 2018 / Övrig artikel
-
Inbjudan till Introduce Investor Day 4 december
6 Nov 2018 / Övrig artikel
-
Swedencare - Asia continues to drive growth
25 Oct 2018 / Analys
-
Swedencare AB (publ) - DELÅRSRAPPORT Q3 - 1 JULI - 30 SEPTEMBER 2018
25 Oct 2018 / Press release
-
Swedencare - Ready, set, pet
18 Oct 2018 / Analys
